Abstract
Objective To investigate intracortical inhibitory mechanisms and muscle function in the Triceps surae of runners with mid-portion Achilles tendinopathy (AT).
Design Cross-sectional study
Methods Runners with (n=11) and without (n=13) AT were recruited. Plantar flexor isometric peak torque and rate of torque development (RTD) were measured using an isokinetic dynamometer. Triceps surae endurance was measured as single leg heel raise (SLHR) to failure test. Short-interval intracortical inhibition (SICI) was assessed using paired-pulse transcranial magnetic stimulation during a sustained contraction at 10% of plantar flexor isometric peak torque.
Results AT presented 13.41% (95%CI:0.76 to 26.0) higher Triceps surae SICI, 68% inhibition (95%CI:58.5 to 76.4) compared to 55% inhibition in the control group (95%CI:45.1 to 63.0). AT performed 28%, - 12.6 (95%CI:-19.4 to -5.7, p=0.001) fewer SLHR repetitions on the most symptomatic side, 27.5 (95%CI:20.7 to 34.3), compared to controls, 38.5 (95% CI:33.2 to 43.8) and 24%, -10.9 (95%CI:-18.4 to -3.3, p=0.008), fewer SLHR repetitions on the non-symptomatic, 29.0 (95%CI:19.4 to 38.6) compared to controls, 38.5 (95%CI:33.2 to 43.8). We found no between-groups differences in isometric peak torque or RTD.
Conclusion Our data suggest greater intracortical inhibition for the Triceps surae muscles for the AT group accompanied by reduced SLHR endurance, without deficits in isometric peak torque or RTD. The increased SICI observed in the AT group could be negatively influencing Triceps surae endurance; thus, rehabilitation aiming to reduce intracortical inhibition should be considered to improve patient outcomes. Furthermore, SLHR is a useful clinical tool to assess plantar flexor function in AT patients.
i. Introduction
Achilles tendinopathy (AT) is an overload injury, most commonly seen in the mid-portion of the tendon, which affects both recreational and elite athletes in sports that involve running and jumping1. AT is a debilitating multifactorial injury, with high recurrence rates1,2. Triceps surae weakness is a key feature in chronic AT and is suggested to be present even before the development of tendinopathy symptoms3–5. Muscle weakness has been reported in individuals with AT as reduced maximal concentric and eccentric strength, and endurance. These deficits in muscle strength and endurance are still observed after years of rehabilitation6,7, even with improvements in pain and function5,8,9. Thus, it is of great clinical relevance to understand the mechanisms underpinning chronic muscle weakness to develop better rehabilitation strategies.
Chronic muscle weakness in individuals with AT could have an origin in the central nervous system. Bilateral sensory and motor deficits (i.e. proprioception and muscle weakness) have been reported in individuals with unilateral tendinopathy, implying involvement of the central nervous system10–12. The central nervous system controls the motor action through different inhibitory and excitatory intracortical mechanisms, which will fine tune and adjust the intensity of the stimuli to achieve the required level of force and control13. Thus, any changes in cortical mechanisms of inhibition could affect motor performance13,14. Short-interval intracortical inhibition (SICI) is a measurement of intracortical mechanisms of inhibition, and it is believed to represent post-synaptic inhibition mediated by GABAA receptors15. SICI reflects the balance between inhibition and facilitation and can be measured using transcranial magnetic stimulation (TMS), by delivering a pair of pulses to the primary motor cortex. Increased SICI has been reported in patella tendinopathy patients, suggesting an imbalance within intracortical mechanisms of inhibition; affecting muscle activation and consequently muscle force14. Therefore, it is possible that increased intracortical inhibition is an important mechanism affecting muscle force in AT patients.
Although increased SICI has been observed in patella tendinopathy14, it is unclear if this is also present in chronic mid-portion AT patients. Thus, this study aimed to investigate intracortical inhibitory mechanisms in runners with mid-portion AT and its influence on plantar flexor isometric peak torque, rate of torque development (RTD), and maximal number of single leg heel raises (SLHR) (endurance measure). We hypothesised that runners with chronic mid-portion AT would present with greater levels of cortical inhibition in the triceps surae and lower plantar flexor isometric peak torque, RTD, and number of SLHR than controls.
ii. Method
This was a cross-sectional study comparing runners with and without mid-portion AT. A sample size of 10 participants was calculated based on the results of Rio et al, 201514 (GPower software parameters: effect size d= 2.63; α err prob: 0.05; power 0.95; n=10). Twenty-four runners were recruited and allocated into two groups: mid-portion AT (n=11) and healthy controls (n=13) (See Table 1 for participants’ characteristics). All participants were endurance runners, recruited from local running clubs. Diagnosis of mid-portion AT was confirmed by an experienced physiotherapist during examination if patients presented with localised mid-portion Achilles tendon pain for more than three months, pain provoked by physical activities in a dose dependent way and had pain with palpation at the mid portion of tendon. Once diagnosis was confirmed, inclusion and exclusion criteria were applied. Inclusion criteria for the AT group were: 1) a diagnosis of mid-portion AT for > 3 months; 2) a running routine of more than twice weekly for > 4 months; and 3) between 18-60 years of age and able to give informed consent. Exclusion criteria for the AT group were: 1) insertional AT; 2) previous rupture or surgery of the Achilles tendon; 3) clinical findings indicating a differential diagnosis for the Achilles tendon pain, such as tendon tear; regular participation in other sports involving high speed running (football, rugby, AFL etc); 4) VISA-A score > 90 points; and 5) any other musculoskeletal injuries of the lower limb; any neurological disorder; or mental health issues affecting consent. Inclusion criteria for the control group were: 1) to be free of any current musculoskeletal injuries of the lower leg; 2) a running routine of more than twice a weekly for > 4 months; and 3) between 18-60 years of age and able to give informed consent. Exclusion criteria for the control group were: 1) previous injury of the Achilles tendon; 2) regular participation in other sports involving high speed running (football, rugby, AFL etc); 3) VISA-A score < 100 points; and 4) any neurological disorder; or mental health issues affecting consent. Prior to testing, all participants read and signed a detailed informed consent document and completed the VISA-A questionnaire16 and a TMS contra-indication questionnaire. This study was approved by the University Human Research and Ethics Committee in line with the Declaration of Helsinki. Data collection was conducted during the COVID-19 pandemic and all safety procedures followed local state government policies.
Plantar flexor isometric peak torque was measured using an isokinetic dynamometer (Biodex Medical Systems, Shirley, New York). For the bilateral AT presentations (n=3), the most symptomatic leg was used and for the control group, the dominant leg was used for testing. Participants were positioned in a seated position (75 degrees of hip flexion) with their knee straight and with the foot perpendicular to shank. Warm up consisted of 2 × 4 s isometric contractions of each participant’s perceived 20, 40, 60 and 80% maximal voluntary isometric contraction intensity. After warm-up, participants performed at least 3 maximal voluntary isometric contractions, until <5% variation was observed between contractions, and the highest value was used. Participants were instructed to contract as hard and fast as possible and received verbal encouragement and visual feedback of force output during the contractions. Absolute RTD was calculated as the average slope of torque-time curve (0-100 ms) relative to onset of contraction. The onset of contraction was determined by visually inspecting the torque trace and calculated from the time immediately after torque increased from baseline. Relative RTD was calculated by dividing the absolute RTD value by the contraction peak torque. After all neuromuscular and corticospinal assessments were completed, participants were instructed to perform the SLHR endurance test to failure from a flat surface, with each leg. Participants were instructed to lift the heel as high as possible, and return to flat position, as many times as possible17. Test was ceased once participants started to perform SLHR test with a reduced range of motion.
After skin preparation, bipolar surface electromyography (sEMG) was used to record electrical signals from soleus (SOL), gastrocnemius medialis (GM) and gastrocnemius lateralis (GL), and a reference electrode was placed on the lateral malleolus. sEMG signal was collected during the corticospinal assessments (see below), and amplified (x1000), band-passed filtered (10-1000 Hz), digitised at 4 kHz. sEMG signals were recorded with PowerLab (16/35) and analysed with LabChart 8 software (AD instruments, New Zealand).
SICI was assessed by measuring motor evoked potential (MEP) amplitudes elicited by TMS over the primary motor cortex. The vertex (Cz) was located according to the 10-20 International System and used as the anatomic reference point for stimulator coil placements. Coil was then, positioned over the motor cortex area related to the lower limb15,18. Single and paired pulses were delivered using a double cone coil connected to a Magstim2 stimulator (Magstim, Dyfed, UK). The coil was positioned over the motor cortex, contralateral to the examined limb and oriented to induce a posterior-anterior current to the motor cortex. The optimal stimulation site for the triceps surae, was identified using a supra-threshold stimulation intensity with a simultaneous background contraction (10% of peak torque)19. The optimal site was considered the area to produce the largest MEP in the SOL15. Thereafter, active motor threshold was determined using a non-parametric algorithm tool for estimating TMS motor threshold, MTAT2.020. Motor threshold was defined as the minimal intensity of TMS output required to produce a positive MEP in the target muscle in at least 5 of 10 trials. A positive MEP was considered when peak-to-peak amplitude was greater than 0.1mV in SOL15.
SICI was investigated using paired pulse stimulation with a conditioning stimulus of 0.8× active motor threshold, followed by a test stimulus of 1.2× active motor threshold, using a 3-ms interstimulus interval18. A single pulse was delivered at the same intensity as the test stimulus of 1.2x active motor threshold, as reference to calculate the percentage of SICI. Participants performed a submaximal contraction of 10% of maximal voluntary torque during transcranial stimulation. To ensure correct background torque participants received real-time visual feedback on a monitor positioned in front of them. The decision of whether to initiate the protocol with SICI or single pulse stimulation was randomised for each participant. Twenty paired pulses and twenty single pulses were delivered. The results were then compared as an index of intracortical inhibition, whereas the higher the SICI value, the greater the intracortical inhibition. SICI is described as a percentage of the averaged peak-to-peak MEP amplitude and it was calculated using the formula: 100 × (conditioned MEP/unconditioned MEP×100)18.
Robust independent samples t test21 was used to compare torque variables and the single leg heel raise test between groups. Robust paired t test21 was used to compare the single leg heel raise test between legs for participants with unilateral AT (n=8). Two-way repeated measures ANOVA was used to compare SICI values between muscles of the triceps surae and between groups. An alpha level of 5% was adopted. Hedge’s g was calculated for estimates of effect size (presented as g). Hedge’s g effect size interpretation is as follows: ≤ 0.2 small effect; ≤ 0.5 medium effect; ≤ 0.8 large effect22. All statistical analyses were conducted using Jamovi software (Version 1.6, Sydney, Australia). Data is presented as means and 95% confidence intervals and effect size.
iii. Results
AT presented 13.41% (95%CI: 0.76 to 26.0) higher Triceps surae SICI, 68% inhibition (95%CI: 58.5 to 76.4) compared to 55% inhibition in the control group (95%CI: 45.1 to 63.0; F = 4.83, η2p 0.180, p=0.039) independent of the tested muscle (Figure 1). No muscle × group interaction was observed (F = 0.189, η2p 0.009, p=0.828). Mean active motor threshold did not differ between groups, 0.1 (95%CI: -5.0 to 5.2).
We found no statistical differences between groups in any of the torque measures, plantar flexor isometric peak torque, -9.6 (95% CI: -48.1 to 28.8, g:-0.14, p=0.597); peak torque normalised for body mass -0.3 (95% CI: -0.9 to 0.1, g:-0.54, p=0.139); RTD 48.7 (95% CI: -101.0 to 198.5, g:0.19, p=0.497) and RTD normalised for % of peak torque 0.5 (95% CI: -0.9 to 1.9, g:0.34, p=0.447). AT performed 28% (95%CI: -19.4 to -5.7, g:-1.0, p=0.001) fewer SLHR repetitions on the most symptomatic side, 27.5 (95%CI: 20.7 to 34.3) compared to controls, 38.5 (95% CI: 33.2 to 43.8 and 24% (95%CI: -18.4 to -3.3, g:-0.9, p=0.008) fewer SLHR repetitions on the non-symptomatic, 29.0 (95%CI: 19.4 to 38.6) compared to controls, 38.5 (95%CI: 33.2 to 43.8), (Figure 2). When only unilateral presentations from the AT group were considered, there were significant between-limb differences with fewer heel raise repetitions performed on the symptomatic than the non-symptomatic leg, - 2.3 (95% CI: -4.0 to -0.5, g:-0.2, p=0.019).
iv. Discussion
This study aimed to determine whether runners with mid-portion AT had: 1) greater intracortical inhibition (measured as SICI) of the triceps surae muscles than healthy controls and 2) lower levels of muscle function (measured as isometric peak torque, rate of torque development and SLHR endurance test). We found that runners with mid-portion AT had higher SICI than controls, accompanied by reduced SLHR endurance but without deficits in isometric peak torque or RTD. The data supports the primary hypothesis that runners with mid-portion AT have greater intracortical inhibition than controls; and partially supports our secondary hypothesis as runners with mid-portion AT have reduced Triceps surae endurance. Contrary to the hypothesis, runners with AT were not weaker nor slower in developing torque than controls during isometric contractions.
As expected, SICI was higher in the AT group, outlining increased intracortical inhibition of the triceps surae muscles (SOL, GM, GL), which could be negatively impacting Triceps surae endurance. To our knowledge, no other studies have investigated intracortical inhibitory mechanisms, using SICI measures, in chronic mid-portion AT. One study14 reported increased SICI in patella tendinopathy. They found a reduction of intracortical inhibition, associated with reduction in tendon pain, following exercise, however this study did not have a control group to compare SICI values. Our results expand these previous findings by demonstrating that patients with mid-portion AT have higher intracortical inhibition, compared to controls. Furthermore, there is evidence that GL has a 22.8% reduction in activation during submaximal isometric contractions in AT23. Thus, if the greater cortical inhibition found in our participants with AT is in fact, negatively affecting their Triceps surae’s endurance capacity, as seen in our participants, rehabilitation should emphasize strategies that have an influence in reducing cortical inhibition, such as heavy resistance training24. Triceps surae heavy resistance training, has yield great improvements in both pain and function in AT patients25.
Although there were no differences between groups in measures of isometric peak torque, the AT group showed a reduced capacity during the SLHR endurance test, suggesting a deficit in Triceps surae endurance. The lack of group difference in plantar flexor isometric peak torque is in line with the result of other studies23,26. In contrast, weakness in plantar flexor dynamic peak torque has been widely reported in AT5,9,12. Perhaps, as observed in other chronic musculoskeletal disorders, such as chronic hamstring strains27, chronic AT presents deficits in dynamic but not in isometric peak torque. To the authors’ knowledge, studies have not yet compared concentric, eccentric, and isometric torque measures from the same group of AT patients, against a control group. Further research analysing different contraction types is necessary to fully characterise Triceps surae’s deficits in AT and help guide better rehabilitation strategies.
Explosive plantar-flexor torque, measured as the RTD, was not different between groups in absolute or normalised values, suggesting chronic AT has no impact on this important parameter. A recent meta-analysis9 found conflicting evidence about reductions in RTD in AT. Our study compared RTD from the most symptomatic leg of AT against healthy controls, whereas all other studies investigating RTD in AT, compared RTD between symptomatic and non-symptomatic legs of the same subjects. As a consequence, there is limited evidence to compare our data to.
Kinesiophobia (fear of movement) influences endurance recovery in AT patients; patients with higher levels of kinesiophobia recovered less of their muscle endurance in a 5-year follow-up2. This interesting finding shows how fear of moving in a certain way or using a specific body part can impact the neural drive to the muscle, possibly involving inhibitory mechanisms within the cortex, as observed in the AT group. The SLHR is a common clinical test of Triceps surae endurance17,28 and function in AT patients28. Our data showed a reduction of 28% in Triceps surae endurance on the symptomatic side and 24% on the non-symptomatic side in unilateral presentations, compared to controls. Studies that have adopted the SLHR endurance test2 or calculated the total work done in dynamometry5 for endurance measurement have also observed a reduction in endurance capacity compared to the non-symptomatic side and to controls, respectively. Bilateral deficits in unilateral presentations have been widely described in chronic AT9,12. These deficits on both symptomatic and non-symptomatic sides, emphasise that the non-symptomatic leg should not be used as comparison for neuromuscular function in AT. It is possible that the degree of cortical inhibition present in our AT participants, is insufficient to impact muscle performance during a brief maximal voluntary isometric contraction, but sufficient to reduce performance during the SLHR test, once additional inhibitory impacts (sensory inhibitory drive to motor neurons or higher centres) are added. Furthermore, it would also be relevant to investigate the impact that neural mechanisms would have in muscular responses to fatigue in AT. The literature shows no association between tendon structure and levels of tendon pain and dysfunction29; however, not having scanned participants tendons could be considered a limitation of this study. Unilateral AT presentations displayed bilateral deficits in muscle endurance; yet, without presenting any symptoms; thus, having scanned participants’ bilateral tendons, would have helped profiling our participants for further analysis and understanding.
v. Conclusion
Runners with mid-portion AT have greater intracortical inhibition to the triceps surae muscles accompanied by a bilateral reduction in triceps surae endurance, despite no deficits in isometric peak torque or explosive torque. The increased SICI observed in the AT group may negatively influencing Triceps surae endurance; thus, rehabilitation strategies aiming to reduce intracortical inhibition should be considered for better outcomes. Furthermore, the SLHR test, is a useful clinical tool to assess Triceps surae function in patients with mid-portion AT as an outcome measure of improvement.
vi. Practical implications
Runners with mid-portion AT have greater intracortical inhibition than healthy runners; and that should be addressed during rehabilitation for better patient outcomes.
SLHR endurance test should continue to be used in clinical practice for assessment and monitoring of Triceps surae function and progression during rehab.
SLHR endurance was reduced bilaterally in unilateral presentations, thus making the non-symptomatic leg not a reliable source of Triceps surae endurance capacity. Clinicians should follow SLHR endurance test normative data for that purpose.
Data Availability
Data material will be send as requested
vii. Acknowledgments
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.